Expressions of CK5/6 and P63 in Cancer Tissues and Their Relationship with Clinicopathological Characteristics inPatientswithNSCLC/ANJin.//Medical InnovationofChina，2025，22(17)：157-160

    [Abstract] Objective： To analyze the expressions of cytokeratin 5/6 (CK5/6) and P63 protein (P63) in cancer tissuesand their relationship with clinicopathological characteristics in patients with non-smal cell lung cancer (NSCLC).Method： A retrospective collection was performedon the clinical data of 18O patients with NSCLC in the First People's Hospital of Fuzhou from January 2O22 to December 2023.The expressions of CK5/6 and P63 in cancer tissues and para-carcinoma tissues was detected by immunohistochemistry，and their relationship with clinicopathological characteristics of NSCLC patients was analyzed.Result：The positive expression rates of CK5/6 and P63 in cancer tissues of NSCLC patients were 73.33% and 77.22% respectively ......